Lisinopril efficacy in blood pressure control
Pro Research Analysisby 
Searched over 200M research papers
Lisinopril Efficacy in Blood Pressure Control
Blood Pressure Reduction in Hypertension
Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, has been shown to significantly lower both systolic and diastolic blood pressure in patients with moderate to severe hypertension. Studies using ambulatory blood pressure monitoring found that lisinopril reduced office, 24-hour, awake, and sleep diastolic blood pressures by substantial margins over a 20-week period, with diastolic blood pressure loads also dropping significantly during treatment. Importantly, these reductions were achieved without affecting heart rate, indicating a targeted antihypertensive effect .
Comparison with Other Antihypertensive Agents
When compared to other antihypertensive medications, lisinopril demonstrates similar or superior efficacy. In direct comparisons, lisinopril was as effective as metoprolol in reducing diastolic blood pressure, but produced a greater reduction in systolic and mean arterial pressures. This effect was maintained over several weeks, and lisinopril was well tolerated by patients . Additionally, lisinopril and enalapril were found to be equally effective in lowering blood pressure at rest, during exercise, and over a 24-hour period, including the critical early morning hours . Compared to amlodipine, lisinopril provided effective blood pressure control, though amlodipine showed more consistent 24-hour control, while lisinopril’s effect was strongest during the daytime .
Dosing Strategies and Blood Pressure Control
Lisinopril is typically administered once daily, but evidence suggests that twice-daily dosing may offer greater reductions in both systolic and diastolic blood pressure compared to the same total daily dose given once daily. Patients on twice-daily regimens experienced a more pronounced decrease in blood pressure, particularly in systolic values . The antihypertensive effect of lisinopril begins within 2 hours, peaks around 6 hours, and lasts at least 24 hours, supporting its use as a once-daily medication for most patients .
Combination Therapy and Special Populations
Combining lisinopril with hydrochlorothiazide enhances its blood pressure-lowering effect, with studies showing average reductions of 32.8 mmHg systolic and 17.1 mmHg diastolic, confirming the value of this combination in clinical practice . In patients with hypertension and type 2 diabetes, lisinopril (alone or in combination) led to well-regulated blood pressure in a majority of patients after three months, with early response to therapy predicting long-term control . Animal studies also support lisinopril’s efficacy in reducing blood pressure in diabetes-related hypertension .
Long-Term Blood Pressure Control and Monotherapy
Large-scale trials indicate that while lisinopril is effective in lowering blood pressure, only about 24% of patients achieve target blood pressure (<140/90 mmHg) with lisinopril monotherapy. Most patients require additional antihypertensive agents to reach optimal control, similar to other drug classes .
Conclusion
Lisinopril is a well-tolerated and effective antihypertensive agent, capable of significantly reducing both systolic and diastolic blood pressure in a variety of patient populations. Its efficacy is comparable to or greater than several other antihypertensive drugs, and it can be further enhanced with combination therapy. While monotherapy is effective for some, most patients will require multiple medications to achieve optimal blood pressure control.
Sources and full results
Most relevant research papers on this topic